MGIM
RCUS icon

M&G Investment Management’s Arcus Biosciences RCUS Stock Holding History

M&G Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-41,631
Closed -$1.46M – 692
2021
Q3 		$1.46M Buy
+41,631
New +$1.3M ﹤0.01% 574
2020
Q3 		– Sell
-15,470
Closed -$387K – 464
2020
Q2 		$387K Buy
+15,470
New +$417K ﹤0.01% 356

Other funds holding RCUS

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

M&G Investment Management's RCUS Position: Q4 2021 in Review

M&G Investment Management sold out of Arcus Biosciences (RCUS) in Q4 2021, closing a stake of 41,631 shares — an estimated $1.46M sold.

M&G Investment Management first reported a position in RCUS in Q2 2020 and held it in 2 quarters. The position peaked at $1.46M in Q3 2021. 142 funds tracked by Wall St. Rank hold RCUS as of Q4 2021.

  • M&G Investment Management reported no remaining Arcus Biosciences position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 41,631 Arcus Biosciences shares in Q4 2021, an estimated $1.46M.
  • M&G Investment Management first reported a position in Arcus Biosciences in Q2 2020 and held it in 2 quarters.
  • M&G Investment Management's Arcus Biosciences position peaked at $1.46M in Q3 2021.
  • 142 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.